PRINCETON, N.J. & PARIS--(BUSINESS WIRE)--STENTYS (STNT.PA), a medical technology company that markets a new generation of innovative stents to treat Acute Myocardial Infarction (AMI), announced today that its CEO and co-founder, Gonzague Issenmann, has been invited to participate in the Piper Jaffray 22nd Annual Health Care Conference in New York City on Tuesday, November 30, 4:30 p.m. ET, at The New York Palace Hotel.
